Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-054757

CEO disposed of 11,318 shares (other)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gline Matthew CEO 2023-11-22 Other disposition 10b5-1 −11,318 $8.68 $98,240 1,017,433 D
Loading xslF345X05/form4.xml…